Relationships between Serum Luteinizing Hormone Level, Endometrial Thickness and Body Mass Index in Polycystic Ovary Syndrome Patients with and without Endometrial Hyperplasia

被引:0
|
作者
Ramezanali, Fariba [1 ]
Khalili, Gholamreza [2 ]
Arabipoor, Arezoo [1 ]
Lankarani, Narges Bagheri [2 ]
Moini, Ashraf [1 ]
机构
[1] ACECR, Royan Inst Reprod Biomed, Reprod Biomed Res Ctr, Dept Endocrinol & Female Infertil, POB 16635-148, Tehran, Iran
[2] ACECR, Royan Inst Reprod Biomed, Reprod Epidemiol Res Ctr, Dept Epidemiol & Reprod Hlth, Tehran, Iran
关键词
Polycystic Ovary Syndrome; Endometrial Hyperplasia; Luteinizing Hormone; Body Mass Index;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: The endometrial hyperplasia measured by ultrasound in polycystic ovary syndrome (PCOS) women is strongly related to pathologic endometrial thickness, but there is no consensus on the relation between serum luteinizing hormone (LH) and either of these factors: pathologic endometrial hyperplasia and body mass index (BMI). Materials and Methods: In this observational cross-sectional study, three hundred fifty infertile PCOS women were involved in this research. An endometrial biopsy was taken by using a pipelle instrument, regardless of menstrual cycle's day and all samples were reported by the same pathologist. Basal serum LH level was compared between two subgroups (hyperplasia and non-hyperplasia). The intended population was divided into three groups according to BMI and basal serum LH, later on the comparison was made in three groups. Chi-square test was applied to compare nominal variables between groups. Mann-Whitney U, and one way ANOVA tests were used to compare means on the basis of the result of normality test. Results: The frequency of endometrial hyperplasia was 2.6%. Endometrial thickness in the patients with endometrial hyperplasia was significantly higher than that of a normal endometrium (10.78 +/- 3.70 vs. 7.90 +/- 2.86 respectively, P=0.020). There was no relation between endometrial hyperplasia and serum LH (P=0.600). The ANOVA test showed serum LH levels were not the same among three BMI groups (P=0.007). Post hoc test was also performed. It showed that the LH level in normal BMI group was significantly higher than those of other groups (P=0.005 and P=0.004), but there was no statistical difference between overweight and obese groups (P=0.8). We found no relationship between BMI and endometrial thickness in PCOS patients (P=0.6). Conclusion: Sonographic endometrial stripe thickness is predictive for endometrial hyperplasia in PCOS women. We could not find out any relationship between serum LH level and BMI with endometrial thickness in PCOS patients. However, our study confirmed a diverse relationship between serum LH level and BMI in PCOS patients.
引用
收藏
页码:36 / 41
页数:6
相关论文
共 50 条
  • [21] Postmenopausal endometrial cancer screening:: is there a correlation between transvaginal sonographic measurement of endometrial thickness and body mass index?
    Güven, MA
    Pata, Ö
    Bakaris, S
    Kafkasli, A
    Mgoyi, L
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2004, 25 (03) : 373 - 375
  • [22] The role of hypertension, body mass index, and serum leptin levels in patients with endometrial hyperplasia during premenopausal period
    Balbi, G.
    Napolitano, A.
    Seguino, E.
    Scaravilli, G.
    Gioia, F.
    Di Martino, L.
    Fusco, D.
    Signoriello, G.
    Grauso, F.
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2012, 39 (03): : 321 - 325
  • [23] Fertility-preserving treatment outcome in endometrial cancer or atypical hyperplasia patients with polycystic ovary syndrome
    Wang, Lulu
    Luo, Xuezhen
    Wang, Qian
    Lv, Qiaoying
    Wu, Pengfei
    Liu, Wei
    Chen, Xiaojun
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 32 (05) : e70
  • [24] Evaluation of a Levonorgestrel-Releasing Intrauterine System for Treating Endometrial Hyperplasia in Patients with Polycystic Ovary Syndrome
    Lin, Min
    Xu, XiaoWen
    Wang, Yi
    Hu, Yue
    Zhao, Yu
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2014, 78 (01) : 41 - 44
  • [25] Relationship between body mass index and disregulation of gonadotropins in polycystic ovary syndrome
    Rechkemmer, A
    Calderón, J
    Barúa, ME
    Solís, J
    RESEARCH PAPERS IN FERTILITY AND REPRODUCTIVE MEDICINE, 2004, 1271 : 30 - 33
  • [26] Deregulation of tissue homeostasis in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia
    Villavicencio, A.
    Bacallao, K.
    Gabler, F.
    Fuentes, A.
    Albornoz, J.
    Casals, A.
    Vega, M.
    GYNECOLOGIC ONCOLOGY, 2007, 104 (02) : 290 - 295
  • [27] The association of body mass index and biochemical hyperandrogenaemia in women with and without polycystic ovary syndrome
    Yasmin, Ephia
    Balen, Adam H.
    Barth, Julian H.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2013, 166 (02) : 173 - 177
  • [28] Serum zonulin level is not elevated in patients with polycystic ovary syndrome without metabolic syndrome
    Cetin, Zeynep
    Kosem, Arzu
    Can, Bulent
    Baser, Ozden
    Catak, Merve
    Turhan, Turan
    Berker, Dilek
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2019, 300 (06) : 1785 - 1790
  • [29] Serum zonulin level is not elevated in patients with polycystic ovary syndrome without metabolic syndrome
    Zeynep Cetin
    Arzu Kosem
    Bulent Can
    Ozden Baser
    Merve Catak
    Turan Turhan
    Dilek Berker
    Archives of Gynecology and Obstetrics, 2019, 300 : 1785 - 1790
  • [30] The correlation of vitamin D level with body mass index in women with polycystic ovary syndrome
    Nowak, Artur
    Wojtowicz, Mariusz
    Baranski, Kamil
    Galczynska, Dominika
    Daniluk, Jakub
    Pluta, Dagmara
    GINEKOLOGIA POLSKA, 2023, 94 (11) : 883 - 888